![](/img/cover-not-exists.png)
PCN17 ESTIMATING THE COST SAVINGS FROM THE INTRODUCTION OF KRAS TESTING IN THE MANAGEMENT OF METASTATIC COLORECTAL CANCER (MCRC) PATIENTS RECEIVING PANITUMUMAB IN GREECE
V Papagianopoulou, A Christodoulopoulou, A Bracco, I YfantopoulosVolume:
11
Year:
2008
Language:
english
DOI:
10.1016/s1098-3015(10)66554-0
File:
PDF, 97 KB
english, 2008